Every day there are new posts in a Facebook group — 89.5 thousand members strong — dedicated to Dexcom G7 issues and complaints. From inaccurate CGM readings and sensor failures to frustrating ...
June 6 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients with type 2 diabetes not ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Dexcom received FDA clearance for its first over-the-counter continuous glucose monitor, called Stelo. The device is intended for people with Type 2 diabetes who do not take insulin. · MedTech Dive · ...
The CONNECT trial, presented at the American Diabetes Association’s 2026 Scientific Sessions in New Orleans, found that 82% of adults with type 2 diabetes who used a Dexcom G7 improved their blood ...
Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo as ...
FDA clears first over-the-counter glucose monitor for children The U.S. Food and Drug Administration said on Friday it has expanded the use of Dexcom's Stelo Glucose Biosensor System to children with ...
June 23, 2003: Apple launches its gorgeous Power Mac G5, a powerhouse desktop computer with a perforated aluminum chassis that earns it the affectionate nickname “the cheese grater.” Starting at an ...
Dexcom has bought Nutrisense, a company that makes a wellness app that uses data from continuous glucose monitors. Nutrisense sells subscription packages that include Dexcom’s over-the-counter CGM, ...
The 15-day G7 CGM in use. [Image courtesy of Dexcom] Nearly halfway through 2026, the milestones are already stacking up for continuous glucose monitor (CGM) maker Dexcom (Nadsaq:DXCM). Finally, last ...
A man wears the Dexcom G7 on his arm while taking photographs. [Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) today announced findings from a study demonstrating the benefits of its G7 CGM in type 2 ...
The global CGM market is projected to reach a valuation of $15.69bn in 2035, as per GlobalData analysis. Credit: Around the World Photos / Shutterstock.com The US Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results